Fezolinetant structure
|
Common Name | Fezolinetant | ||
---|---|---|---|---|
CAS Number | 1629229-37-3 | Molecular Weight | 358.393 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 623.0±65.0 °C at 760 mmHg | |
Molecular Formula | C16H15FN6OS | Melting Point | N/A | |
MSDS | N/A | Flash Point | 330.5±34.3 °C |
Use of FezolinetantFezolinetant is an antagonist of the neurokinin 3 receptor (NK3R), used for the treatment of menopausal hot flushes. |
Name | Fezolinetant |
---|---|
Synonym | More Synonyms |
Description | Fezolinetant is an antagonist of the neurokinin 3 receptor (NK3R), used for the treatment of menopausal hot flushes. |
---|---|
Related Catalog | |
In Vivo | Fezolinetant (ESN364, 1 mg/kg, iv bolus) reversibly inhibits the regular, pulsatile secretion of LH in the ovarectomized ewe. ESN364 represses the pulse pattern of LH in all treated animals. ESN364 (5 mg/kg, p.o.) lowers plasma LH, but not FSH, in the castrated monkey. ESN364 (10, 25, 50 mg/kg, orally) also blocks the LH surge and decreases ovarian hormone levels throughout the menstrual cycle in monkeys[1]. |
Animal Admin | On the day of the experiment, the NK3R antagonist ESN364 is formulated in physiological saline with 9% 2-hydroxypropyl-β-cyclodextrin at a concentration of 2 mg/mL. At 240 minutes after the initiation of blood sampling, ESN364 (1 mg/kg, n=5) or vehicle (n=5) is administered by an iv bolus injection at a dose volume of 0.5 mL/kg through the jugular cannulae, and the injected material is flushed into the animal with 5 mL of heparinized saline. Blood sampling resumes at the indicated intervals following this iv administration. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 623.0±65.0 °C at 760 mmHg |
Molecular Formula | C16H15FN6OS |
Molecular Weight | 358.393 |
Flash Point | 330.5±34.3 °C |
Exact Mass | 358.101196 |
LogP | 0.96 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.760 |
Storage condition | 2-8℃ |
(4-Fluorophenyl)[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]methanone |
Methanone, [(8R)-5,6-dihydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl](4-fluorophenyl)- |
83VNE45KXX |
UNII:83VNE45KXX |
fezolinetant |